Evolution of Parkinson's disease. Conclusions

被引:0
|
作者
Garcia-Ruiz, Pedro J. [1 ]
机构
[1] Fdn Jimenez Diaz, Serv Neurol, Ave Reyes Catolicos 2, E-28040 Madrid, Spain
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:S21 / S21
页数:1
相关论文
共 50 条
  • [41] Rivastigmine for dementia associated with Parkinson's disease.
    Morgan J.
    Sethi K.D.
    Current Neurology and Neuroscience Reports, 2005, 5 (4) : 263 - 265
  • [42] Surgical treatment modalities in Parkinson's disease.
    Alesch, F
    Deecke, L
    NEUROPSYCHIATRIE, 1995, 9 : S42 - S44
  • [43] Principles of drug treatment in Parkinson's disease.
    Schnaberth, G
    NEUROPSYCHIATRIE, 1995, 9 : S2 - S3
  • [44] Astrocytes, microglia and neurotrophins in Parkinson's disease.
    Knott, C
    Wilkin, GPI
    Stern, G
    Welcher, A
    JOURNAL OF NEUROCHEMISTRY, 1999, 73 : S25 - S25
  • [45] The role of anticholinergics in the treatment of Parkinson's disease.
    Danielczyk, W
    Schnaberth, G
    NEUROPSYCHIATRIE, 1995, 9 : S25 - S26
  • [46] Erectile dysfunction and risk of Parkinson's disease.
    Gao, X.
    Chen, H.
    Schwarzschild, M. A.
    Rimm, E. B.
    Ascherio, A.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2007, 165 (11) : S68 - S68
  • [47] Diagnostic criteria for idiopathic Parkinson's disease.
    Viallet, F
    REVUE NEUROLOGIQUE, 2000, 156 : 30 - 35
  • [48] Depression and subsequent risk of Parkinson's disease.
    Van Den Eeden, SK
    Benedict, KS
    Tanner, CM
    Bernstein, A
    Nelson, LM
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2001, 153 (11) : S240 - S240
  • [49] PSYCHOSIS IN PARKINSON'S DISEASE. A CASE REPORT
    Diaz Marrero, G.
    Suarez Benitez, M. N.
    Vera-Barrios, E.
    Hernandez-Dorta, A.
    Gonzalez, I.
    Quant-Herrera, P.
    Barrau Alonso, V. M.
    Yelmo, S.
    EUROPEAN PSYCHIATRY, 2013, 28
  • [50] Characterization of Pisa syndrome in Parkinson's disease.
    Clark, T.
    Nutt, J.
    Horak, F.
    Mancini, M.
    Jurado, M.
    Hullar, T.
    MOVEMENT DISORDERS, 2017, 32